A multicentre, open label, phase I/ randomised Phase II study to evaluate safety, pharmacokinetics, and efficacy of BIBF 1120 in comparison with oral sorafenib for advanced hepatocellular carcinoma patients.

Project Details

Short titleA multicentre, open label, phase I/ randomised Phase II study to evaluate safety, pharmacokinetics, and efficacy of BIBF 1120 in comparison with oral sorafenib for advanced hepatocellular carcinoma patients.
StatusFinished
Effective start/end date28/10/0931/12/19

Funding

  • Uhb Nhs Trust